Metraipolis › archive › dc_d27ed26bd24e

Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development — Europe PMC PMID:37668303

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37668303
DOI
10.1289/ehp12381
License (as archived)
CC0-1.0
Archived
2026-10-07T12:27:00.599Z
SHA-256 of the archived text
1c9991f25c7d54dd839426693aa7d6c71bd9603b7fea6fdbf431ad1b8ba2e485
Stable URL of this page
https://metraipolis.com/documento/dc_d27ed26bd24e

How to cite

Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development — Europe PMC PMID:37668303 — Europe PMC (en), https://europepmc.org/article/MED/37668303 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d27ed26bd24e (Metraipolis archive dc_d27ed26bd24e, sha256 1c9991f25c7d54dd839426693aa7d6c71bd9603b7fea6fdbf431ad1b8ba2e485)
BibTeX
@misc{dcd27ed26bd24e,
  title = {Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development — Europe PMC PMID:37668303},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37668303},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d27ed26bd24e; sha256 1c9991f25c7d54dd839426693aa7d6c71bd9603b7fea6fdbf431ad1b8ba2e485},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37668303. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Newborns can be exposed to inorganic arsenic (iAs) through contaminated drinking water, formula, and other infant foods. Epidemiological studies have demonstrated a positive association between urinary iAs levels and the risk of developing nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults. Objectives: The present study examined how oral iAs administration to neonatal mice impacts the intestinal tract, which acts as an early mediator for NAFLD. Methods: Neonatal mice were treated with a single dose of iAs via oral gavage. Effects on the small intestine were determined by histological examination, RNA sequencing, and biochemical analysis. Serum lipid profiling was analyzed by fast protein liquid chromatography (FPLC), and hepatosteatosis was characterized histologically and biochemically. Liver X receptor-alpha (LXRα) knockout (Lxrα-/-) mice and liver-specific activating transcription factor 4 (ATF4)-deficient (Atf4ΔHep) mice were used to define their roles in iAs-induced effects during the neonatal stage. Results: Neonatal mice exposed to iAs via oral gavage exhibited accumulation of dietary fat in enterocytes, with higher levels of enterocyte triglycerides and free fatty acids. These mice also showed accelerated enterocyte maturation and a longer small intestine. This was accompanied by higher levels of liver-derived very low-density lipoprotein and low-density lipoprotein triglycerides, and a lower level of high-density lipoprotein cholesterol in the serum. Mice exposed during the neonatal period to oral iAs also developed hepatosteatosis. Compared with the control group, iAs-induced fat accumulation in enterocytes became more significant in neonatal Lxrα-/- mice, accompanied by accelerated intestinal growth, hypertriglyceridemia, and hepatosteatosis. In contrast, regardless of enterocyte fat accumulation, hepatosteatosis was largely reduced in iAs-treated neonatal Atf4ΔHep mice. Conclusion: Exposure to iAs in neonatal mice resulted in excessive accumulation of fat in enterocytes, disrupting lipid homeostasis in the serum and liver, revealing the importance of the gut-liver axis and endoplasmic reticulum stress in mediating iAs-induced NAFLD at an early age. https://doi.org/10.1289/EHP12381.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2023 (prima pubblicazione 2023-09-05).
Identificativi: PMID 37668303 · PMCID PMC10478510 · DOI 10.1289/ehp12381.
Descrittori MeSH principali: Arsenic; Non-alcoholic Fatty Liver Disease.
Pagina: https://europepmc.org/article/MED/37668303 — https://doi.org/10.1289/ehp12381. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T11:59:26.216Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.